These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35282012)

  • 61. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
    Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
    J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase.
    Ding Y; Cao Z; Cao L; Ding G; Wang Z; Xiao W
    Sci Rep; 2017 Apr; 7():45723. PubMed ID: 28393840
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.
    Marjuki H; Mishin VP; Chesnokov AP; De La Cruz JA; Davis CT; Villanueva JM; Fry AM; Gubareva LV
    J Virol; 2015 May; 89(10):5419-26. PubMed ID: 25740997
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance.
    McKimm-Breschkin JL
    Influenza Other Respir Viruses; 2013 Jan; 7 Suppl 1(Suppl 1):25-36. PubMed ID: 23279894
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prolonged shedding of amantadine- and oseltamivir-resistant influenza A(H3N2) virus with dual mutations in an immunocompromised infant.
    Ruiz-Carrascoso G; Casas I; Pozo F; González-Vincent M; Pérez-Breña P
    Antivir Ther; 2010; 15(7):1059-63. PubMed ID: 21041923
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Emergence of Oseltamivir-Resistant Seasonal Influenza A (H1N1) Virus in Korea During the 2008-2009 Season.
    Choi WY; Yang I; Kim S; Lee N; Kwon M; Lee JY; Kang C
    Osong Public Health Res Perspect; 2011 Dec; 2(3):178-85. PubMed ID: 24159470
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
    Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of the viral hemagglutinin in the anti-influenza virus activity of newly synthesized polycyclic amine compounds.
    Torres E; Duque MD; Vanderlinden E; Ma C; Pinto LH; Camps P; Froeyen M; Vázquez S; Naesens L
    Antiviral Res; 2013 Sep; 99(3):281-91. PubMed ID: 23800838
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of influenza virus replication by adlay tea.
    Nagai E; Iwai M; Koketsu R; Sogabe R; Morimoto R; Suzuki Y; Ohta Y; Okuno Y; Ohshima A; Enomoto T; Isegawa Y
    J Sci Food Agric; 2018 Mar; 98(5):1899-1905. PubMed ID: 28902408
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
    Cheng H; Wan J; Lin MI; Liu Y; Lu X; Liu J; Xu Y; Chen J; Tu Z; Cheng YS; Ding K
    J Med Chem; 2012 Mar; 55(5):2144-53. PubMed ID: 22332894
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Insights into the direct anti-influenza virus mode of action of Rhodiola rosea.
    Döring K; Langeder J; Duwe S; Tahir A; Grienke U; Rollinger JM; Schmidtke M
    Phytomedicine; 2022 Feb; 96():153895. PubMed ID: 35026524
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.
    Zaraket H; Saito R; Wakim R; Tabet C; Medlej F; Reda M; Baranovich T; Suzuki Y; Dapat C; Caperig-Dapat I; Dbaibo GS; Suzuki H
    J Med Virol; 2010 Jul; 82(7):1224-8. PubMed ID: 20513088
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oseltamivir-zanamivir combination therapy suppresses drug-resistant H1N1 influenza A viruses in the hollow fiber infection model (HFIM) system.
    Pires de Mello CP; Drusano GL; Adams JR; Shudt M; Kulawy R; Brown AN
    Eur J Pharm Sci; 2018 Jan; 111():443-449. PubMed ID: 29079337
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses.
    Kim JI; Lee S; Lee GY; Park S; Bae JY; Heo J; Kim HY; Woo SH; Lee HU; Ahn CA; Bang HJ; Ju HS; Ok K; Byun Y; Cho DJ; Shin JS; Kim DY; Park MS; Park MS
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31167918
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
    Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
    Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir.
    Samson M; Abed Y; Desrochers FM; Hamilton S; Luttick A; Tucker SP; Pryor MJ; Boivin G
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5220-8. PubMed ID: 24957832
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008.
    Dijkstra F; Jonges M; van Beek R; Donker GA; Schellevis FG; Koopmans M; van der Sande MA; Osterhaus AD; Boucher CA; Rimmelzwaan GF; Meijer A
    Open Virol J; 2011; 5():154-62. PubMed ID: 22253652
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
    Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
    J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug Repurposing Identifies Inhibitors of Oseltamivir-Resistant Influenza Viruses.
    Bao J; Marathe B; Govorkova EA; Zheng JJ
    Angew Chem Int Ed Engl; 2016 Mar; 55(10):3438-41. PubMed ID: 26833677
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.
    Wong DD; Choy KT; Chan RW; Sia SF; Chiu HP; Cheung PP; Chan MC; Peiris JS; Yen HL
    J Virol; 2012 Oct; 86(19):10558-70. PubMed ID: 22811535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.